Co-Diagnostics shareholders elect directors, approve executive pay, ratify auditor at annual meeting

Co-Diagnostics, Inc.

Elected Dwight Egan (6,103,488 for) and Eugene Durenard (4,017,019 for) as Class II directors for three-year terms.
Advisory vote on executive compensation approved: 6,426,011 for, 1,221,093 against, 236,466 abstain.
Ratified Tanner LLC as independent auditor for 2023: 14,966,948 for, 334,913 against, 393,098 abstain.
Broker non-votes were 7,811,389 on director election and executive compensation proposals.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Co-Diagnostics, Inc. shareholders approved Adoption, on an advisory basis, of a non-binding resolution approving the compensation of the Company's named executive officers. at the 2023-08-30 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-08-30

Exact text from the filing

Proposal No. 2 : A proposal to adopt, on an advisory basis, a non-binding resolution approving the compensation of the Company’s named executive officers, as described in the Proxy Statement under “Executive Compensation.” This proposal was adopted.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Co-Diagnostics, Inc. shareholders approved Election of two Class II directors to hold office for a term expiring at the annual meeting of stockholders to be held in 2026 or until their respective successors are elected and qualified. at the 2023-08-30 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-08-30

Exact text from the filing

Proposal No. 1 : A proposal to elect two Class II directors to hold office for a term expiring at the annual meeting of stockholders to be held in 2026 or until their respective successors are elected and qualified. This proposal was approved and Messrs. Egan and Durenard were elected to the board of directors of the Company.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Co-Diagnostics, Inc. shareholders approved Ratification of the Audit Committee's appointment of Tanner LLC as the Company's independent registered public accounting firm for the year ending December 31, 2023. at the 2023-08-30 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-08-30

Exact text from the filing

Proposal No. 3 : A proposal to ratify the Audit Committee’s appointment of Tanner LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2023. This proposal was ratified.

View on SEC.gov

Browse all shareholder votes →

Co-Diagnostics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-031051

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.